Statistics for Cidara Therapeutics (id:5624 CDTX)

Valuation metrics

Market cap

94.78M

Enterprise value

-67,797,664.00

Trailing P/E (ttm)

-3.92

Forward P/E

-1.72

PEG ratio

-1.72

Price/Sales (ttm)

1.76

Price/Book (mrq)

0.71

Enterprise Value/Revenue

-1.26

Enterprise Value/EBITDA

2.25

Overview

Shares outstanding

7.04M

Float

4.21M

Shares short

66.98K

% Held by insiders

0.05%

% Held by institutions

0.52%

Average volume (10 days)

17.36K

Average volume (90 days)

Price summary

52-Week low

10.00

52-Week high

24.40

52-Week change

30.39%

Beta

0.99

50-Day moving average

11.59

200-Day moving average

12.95

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

April 24th, 2024

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

June 30th, 2024

Profitability

Profit margin

-211.35%

Operating margin

-3,675.83%

Operational effectiveness

Return on assets

-15.66%

Return on equity

-153.39%

Income statement

Revenue (ttm)

11.88

Revenue per share (ttm)

11.88

Quarterly revenue growth (yoy)

Gross profit (ttm)

62.38M

EBITDA

-30,107,000.00

Net income to common (ttm)

-112,242,000.00

Diluted EPS (ttm)

-24.60

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

164.37M

Total cash per share (mrq)

23.35

Total debt (mrq)

4.30M

Total Debt/Equity (mrq)

3.28

Current ratio (mrq)

425.30%

Book value per share (mrq)

-1.81

Cash flow

Cash flow statement

-124,780,000.00

Levered free cash flow (LFCF)

-323,875.00